KK, H., JA, K., AR, G., HS, W., M, G., RB, N., . . . L, E. (2023). Impaired neurocognitive functioning 3 months following diagnosis of high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group. Pediatric blood & cancer, 70(7), e30350. https://doi.org/10.1002/pbc.30350
Chicago Style (17th ed.) CitationKK, Hardy, et al. "Impaired Neurocognitive Functioning 3 months Following Diagnosis of High-risk Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group." Pediatric Blood & Cancer 70, no. 7 (2023): e30350. https://doi.org/10.1002/pbc.30350.
MLA (9th ed.) CitationKK, Hardy, et al. "Impaired Neurocognitive Functioning 3 months Following Diagnosis of High-risk Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group." Pediatric Blood & Cancer, vol. 70, no. 7, 2023, p. e30350, https://doi.org/10.1002/pbc.30350.